Collagen Corp. regulatory update

CGEN (Palo Alto) received FDA approval for its Collagraft Strip, a second-generation product for the treatment of acute long bone fractures and traumatic osseous defects. Bristol-Myers Squibb’s Zimmer Inc. subsidiary, which co-developed the product and holds U.S. and Asian marketing rights, will begin marketing immediately. ...